Regulations.gov document
Attachment 2 - "Hydrolytic Conversion of Lisdexamfetamine Dimesylate to the Active Moiety…
Supporting & Related Material · FDA-2009-N-0184 · posted Jun 8, 2009
Key facts
| Document ID | FDA-2009-N-0184-0013 |
|---|---|
| Title | Attachment 2 - "Hydrolytic Conversion of Lisdexamfetamine Dimesylate to the Active Moiety, d-Amphetamine (Presentation, May 14-18, 2009)" - [Shire Pharmaceuticals (Covington & Burling, LLP) - Comment] |
| Document type | Supporting & Related Material |
| Subtype | BKG-Background Material |
| Agency | FDA |
| Docket | FDA-2009-N-0184 |
| Posted | Jun 8, 2009 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: